Alex Thompson

Stock Analyst at Stifel

(0)
# 4856
Out of 5,255 analysts
42
Total ratings
22.22%
Success rate
-29.75%
Average return
20 Stocks
Name Action Price Target Current % Upside Ratings Updated
THRD Third Harmonic Bio
Downgrades: Hold
23 5
5.13 -2.53% 2 Mar 28, 2025
AVTX Avalo Therapeutics
Initiates Coverage On: Buy
36
4.78 653.14% 1 Mar 25, 2025
CRNX Crinetics Pharmaceut...
Initiates Coverage On: Buy
60
32.42 85.07% 1 Mar 25, 2025
ASND Ascendis Pharma
Maintains: Strong Buy
200 207
164.15 26.1% 2 Nov 15, 2024
ORKA Oruka Therapeutics
Initiates Coverage On: Buy
49
n/a n/a 1 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
30 57
n/a n/a 4 Jul 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
485 500
615.39 -18.75% 4 Jun 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
36 54
14.11 282.71% 2 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
44
21.61 103.61% 1 Feb 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
6 2
1.2 66.67% 5 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
8 10
18.33 -45.44% 2 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
66 69
39.44 74.95% 2 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
2 1
1.34 -25.37% 4 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
40
13.49 196.52% 2 Sep 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
40
0.88 4445.45% 1 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
n/a n/a 1 Jul 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
28 34
14.67 131.77% 2 Jul 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
43 41
n/a n/a 3 Jun 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
33
1.46 2160.27% 1 Dec 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
37
n/a n/a 1 Sep 7, 2022